Loss of T Cell Antigen Recognition Arising from Changes in Peptide and Major Histocompatibility Complex Protein Flexibility: IMPLICATIONS FOR VACCINE DESIGN

Documenti analoghi

• Peptide Modulation of Class I Major Histocompatibility Complex Protein Molecular Flexibility and the Implications for Immune Recognition
  di: Hawse, William F., et al.
  Pubblicazione: (2013)
• T cell receptors used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms
  di: Borbulevych, Oleg Y., et al.
  Pubblicazione: (2011)
• Structures of MART-1(26/27–35) Peptide/HLA-A2 Complexes Reveal a Remarkable Disconnect between Antigen Structural Homology and T Cell Recognition
  di: Borbulevych, Oleg Y., et al.
  Pubblicazione: (2007)
• Increased Immunogenicity of an Anchor-Modified Tumor-Associated Antigen Is Due to the Enhanced Stability of the Peptide/MHC Complex: Implications for Vaccine Design
  di: Borbulevych, Oleg Y., et al.
  Pubblicazione: (2005)
• Specific T cell recognition of kinetic isomers in the binding of peptide to class II major histocompatibility complex
  di: Rabinowitz, Joshua D., et al.
  Pubblicazione: (1997)